A deal we should refuse
Last updated 5/17/2007 at Noon
Drug re-importation has long been an issue in American politics. It’s not surprising, therefore, that the Senate once again is considering whether US consumers should be able to purchase medicines originally manufactured in the United States, exported abroad, then later re-imported back into the country.
But hidden in this latest legislation is a “forced sale” provision that not only would cause enormous harm to the health care industry, but also set a dangerous precedent for government interference into private business deals.
“Forced sale” is quite simple – the government fo...